pharma · Analgesia · Postoperative Pain · HRTX
Heron Therapeutics
Heron Therapeutics trial registry — 30 ClinicalTrials.gov studies with program phase, status, and indication context.
100 Regency Forest Dr, Cary, North Carolina 27518, US HQ
1983 Founded
188 Employees
Public company Type
HRTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- 100 Regency Forest Dr, Cary, North Carolina 27518, US
- Founded
- 1983
- Employees
- 188
- Programs
- 18
- Drugs
- 17
- Patents
- 46
Heron Therapeutics clinical trials
Registry index of 30 ClinicalTrials.gov studies linked to Heron Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Heron Therapeutics trial registry — 30 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Heron Therapeutics.
-
SUSTOL — Approved
Clinical update -
GRANISETRON EXTENDED RELEASE INJECTION (GERSC) — Phase 2
Clinical update -
Bupivacaine liposome injectable suspension — Approved
Clinical update -
Bupivacaine Hydrochloride — Approved
Clinical update -
Bupivacaine HCI without epinephrine — Phase 2
Clinical update -
B10 L-BPA Injection — Phase 2
Clinical update -
B10 L-BPA Injection — Phase 2
Clinical update -
Aprepitant injectable emulsion — Phase 2
Clinical update